{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azelaic root_mixture_components_substance_refPname in Mixture Component Name (approximate match)
Status:
US Approved Rx
(2019)
Source:
ANDA206455
(2019)
Source URL:
First approved in 1997
Source:
NaturVet ArthriSoothe by The Garmon Corporation
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(1991)
Source:
BLA020032
(1991)
Source URL:
First approved in 1991
Source:
BLA020032
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2012)
Source:
ANDA091112
(2012)
Source URL:
First approved in 1971
Source:
FREAMINE 8.5% by B BRAUN
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
USAN:PLECTRANTHUS AMBOINICUS EXTRACT [USAN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
INN:rintatolimod [INN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
USAN:OMEGA-3-PENTAENOIC ACIDS [USAN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT01781559: Not Applicable Interventional Completed Endothelial Dysfunction
(2012)
Source URL:
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE